Related Experiment Video
Updated: Feb 22, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
A new mechanism regulating microglial NLRP3 inflammasome: FMR1 mediates NLRP3 mRNA stability
Qian Deng1, Qianqian Bai2, Yang Yang2
1Department of Pharmacy, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, China.
Background:
The NLRP3 inflammasome drives chronic inflammation and contributes to the pathogenesis of multiple sclerosis (MS). This study aimed to elucidate a novel post-transcriptional regulatory mechanism controlling NLRP3 expression in microglia under lipopolysaccharide (LPS) stimulation.
Methods:
The experimental autoimmune encephalomyelitis (EAE) mouse model of MS was established and divided into four groups: Sham, EAE, EAE + Lv-con (control lentivirus), and EAE + Lv-FMR1 (FMR1-overexpressing lentivirus). BV2 microglial cells were stimulated with LPS and adenosine triphosphate (ATP). mRNA and protein levels were assessed by qPCR, western blot, immunofluorescence, and immunohistochemistry. Caspase-1 activity and IL-1β/IL-18 levels were quantified using commercial assay kits. RNA-binding proteins (RBPs) interacting with NLRP3 mRNA were identified by RNA pull-down combined with mass spectrometry. NLRP3 mRNA stability was analyzed using Actinomycin D.
Results:
NLRP3 inflammasome activation was confirmed in the spinal cords of EAE mice and in LPS/ATP-stimulated BV2 cells. Lentivirus-mediated overexpression of FMR1 in EAE mice attenuated microglial activation (reduced IBA-1) and decreased NLRP3 expression compared to the EAE + Lv-con control group. Immunohistochemistry confirmed reduced caspase-1 deposition in the EAE + Lv-FMR1 group. Mechanistically, FMR1 directly interacted with the 3' untranslated region (3'UTR) of NLRP3 mRNA in LPS/ATP-treated BV2 cells, leading to mRNA destabilization and consequent suppression of NLRP3 protein expression. Functionally, FMR1 inhibited NLRP3 inflammasome activation by downregulating NLRP3.
Conclusion:
FMR1 suppresses NLRP3 inflammasome activation in both EAE mice and microglial cell models by destabilizing NLRP3 mRNA. This suggests that FMR1 possesses therapeutic potential for MS by dually regulating neuroinflammation and NLRP3-driven pathology.
Insights
Fragile X mental retardation homolog 1 (FMR1) suppresses NLRP3 inflammasome activation in multiple sclerosis (MS) models by destabilizing NLRP3 mRNA, offering therapeutic potential for MS by regulating neuroinflammation.
Area of Science:
- Neuroscience
- Immunology
- Molecular Biology
Background:
- The NLRP3 inflammasome is implicated in chronic inflammation and multiple sclerosis (MS) pathogenesis.
- Microglia play a key role in neuroinflammation, and their activation is central to MS.
- Understanding NLRP3 regulation in microglia is crucial for developing MS therapies.
Purpose of the Study:
- To investigate a novel post-transcriptional regulatory mechanism of NLRP3 expression in microglia.
- To determine the role of FMR1 in controlling NLRP3 inflammasome activation.
- To explore the therapeutic potential of FMR1 in MS models.
Main Methods:
- Established an experimental autoimmune encephalomyelitis (EAE) mouse model of MS.
- Utilized lentivirus-mediated overexpression of FMR1 in EAE mice and BV2 microglial cells.
- Stimulated BV2 cells with lipopolysaccharide (LPS) and adenosine triphosphate (ATP).
- Assessed mRNA and protein levels using qPCR, western blot, and immunohistochemistry.
- Quantified caspase-1 activity and IL-1β/IL-18 levels.
- Identified RNA-binding proteins interacting with NLRP3 mRNA via RNA pull-down and mass spectrometry.
- Analyzed NLRP3 mRNA stability using Actinomycin D.
Main Results:
- NLRP3 inflammasome activation was confirmed in EAE mice and stimulated BV2 cells.
- FMR1 overexpression in EAE mice reduced microglial activation (IBA-1) and NLRP3 expression.
- FMR1 directly interacted with the 3' UTR of NLRP3 mRNA, leading to its destabilization.
- FMR1 suppressed NLRP3 protein expression and inhibited NLRP3 inflammasome activation.
Conclusions:
- FMR1 acts as a suppressor of NLRP3 inflammasome activation by destabilizing NLRP3 mRNA.
- FMR1 demonstrates therapeutic potential for MS by modulating neuroinflammation and NLRP3-driven pathology.
- Targeting FMR1 could be a novel strategy for treating multiple sclerosis.
Related Concept Videos
Regulation of the Unfolded Protein Response
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nonsense-mediated mRNA Decay
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

